Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ependymomics: Multiomic Approach to Radioresistance of Ependymomas in Children and Adolescents

NCT05151718 is registered in ClinicalTrials.gov with Institut Claudius Regaud as lead sponsor.

NCT NCT05151718
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05151718 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ependymomics: Multiomic Approach to Radioresistance of Ependymomas in Children and Adolescents
Lead sponsor
Institut Claudius Regaud
Phase
Observational
Overall status
Recruiting
Start date
September 30, 2021
Completion date
September 30, 2026
Enrollment
370 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ependymoma of brain, pediatric solid tumor